Annual report pursuant to Section 13 and 15(d)

Income Tax - Summary of Tax Effects of Temporary Differences and Carryforwards Rise to Deferred Tax Assets and Liabilities (Detail)

v3.22.4
Income Tax - Summary of Tax Effects of Temporary Differences and Carryforwards Rise to Deferred Tax Assets and Liabilities (Detail) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets    
Tax basis in excess of book value of assets $ 899,000 $ 897,000
Non-capital loss carryforwards 43,380,000 39,356,000
Research and development deductions and credits 8,942,000 7,058,000
Stock options 1,042,000 702,000
§59(e) Capitalized R&D expenses 11,342,000 7,159,000
Other 334,000 316,000
Total deferred tax assets 65,939,000 55,488,000
Valuation allowance (65,546,000) (55,082,000)
Net deferred assets 393,000 406,000
Deferred tax liabilities    
Other (393,000) (406,000)
Total deferred tax liabilities (393,000) $ (406,000)
Net deferred tax assets $ 0